Corporate Fuel
Corporate Fuel, established in 2005 and headquartered in New York, is a boutique investment bank and private equity firm. It specializes in advising middle-market companies on strategic options, mergers and acquisitions, capital raising, and leadership recruitment to help them realize full value. Through its private equity arm, Corporate Fuel Partners, it invests in later-stage, growth-oriented companies in sectors such as healthcare, technology, and manufacturing, with a focus on the Northeastern United States. The firm typically invests $2 million to $5 million initially, with follow-on investments up to $10 million, in companies generating $5 million to $100 million in revenue and $1 million to $4 million in EBITDA.
Top Stages
3 past transactions
Vescent Photonics
Seed Round in 2024
Vescent develops and manufactures novel electro-optic and laser technologies. We offer frequency-stabilized diode laser systems, precision control electronics, accessory electro-optic modules, and mode-locked lasers and frequency combs. Our scientists and engineers are continuously developing cutting-edge solutions to technical challenges. HQ: 14998 W 6th Ave, Suite 700, Golden, CO 80401
EnergyWatch
Series A in 2018
EnergyWatch Inc. is a leading provider of energy cost reduction solutions, specializing in utility data analytics and reporting across various sectors, including commercial real estate, industrial manufacturing, retail, education, and government facilities. Founded in 2000 and based in New York, the company operates its Watch Wire platform, which delivers descriptive, predictive, and prescriptive analytics. This platform enables clients to analyze the impact of operational and capital improvements on utility costs, measure and verify key performance indicators, and strategically procure energy while understanding energy rates. EnergyWatch partners with notable organizations such as PXR, New York Life, Brookfield, CBRE, and Highgate Hotels, simplifying complex utility data and rate structures to provide actionable insights for decision-makers.
AllerGenis
Seed Round in 2017
AllerGenis, Inc. is a diagnostic company based in Hatfield, Pennsylvania, that specializes in the detection and management of food allergies and other immune response disorders. Founded in 2017 through a collaboration with Dr. Hugh Sampson from the Icahn School of Medicine at Mount Sinai, AllerGenis leverages the world’s largest database of patient phenotypic data, derived from epitope mapping and clinical histories, to develop precision diagnostics. The company operates a CLIA-certified laboratory and offers advanced blood test services that analyze individualized reaction patterns, providing healthcare providers with detailed insights to enhance the diagnosis, assessment, and monitoring of patients with food allergies. Through its innovative approach, AllerGenis aims to improve the understanding and management of food allergies for both clinicians and patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.